AI
ByDid the Zealand Pharma–Roche Obesity Partnership Hit an Early Roadblock?
A closely watched obesity drug collaboration between Zealand Pharma and Roche has encountered an unexpected setback after early…
Indian Biopharma Faces Freight Surge Amid US-Iran Escalation
India’s biopharma sector confronts $300-500M export losses as US-Iran war disrupts Gulf shipping, spiking container surcharges to $3,500–$5,000…
What broader implications does Zealand Pharma’s petrelintide trial setback raise for the GLP-1 obesity market?
Trial Context Recap ZUPREME-1 delivered 10.7% peak weight loss over 42 weeks across 493 patients, surpassing placebo but…
The $10B+ Pharma Titans of 2025: Fortress Builders or House of Cards?
In 2025, only nine pharmaceutical brands crossed the $10 billion revenue threshold, collectively generating $125B+ while representing 25% of global pharma sales—yet their…
AI in Life Sciences: A Multi-Billion Dollar Transformation Reshaping Drug Discovery and Healthcare
Artificial intelligence is rapidly becoming one of the most transformative forces in the life sciences industry. Global investment…
Strategic Industry Analysis: What the Biggest Biopharma Deals of 2025 Reveal About the Future of Drug Innovation
The global biopharmaceutical industry experienced a powerful wave of strategic dealmaking in 2025 as major pharmaceutical companies accelerated…
